Roxane Wants DOJ Sanctioned For Spoliation

The U.S. Department of Justice allegedly spoliated evidence in the average wholesale price antitrust litigation that could reduce Boehringer Ingelheim Roxane Inc.'s damages by up to $1 billion, the pharmaceutical company...

Already a subscriber? Click here to view full article